Novo Nordisk rises as early weight-loss pill data impresses Street - InvestingChannel

Novo Nordisk rises as early weight-loss pill data impresses Street

Shares of Novo Nordisk (NVO) are on the rise on Wednesday following the drugmaker’s presentation of early-stage trial results for its experimental weight-loss pill, which seems to have impressed Wall Street analysts. BMO Capital says… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id3981980/-Novo-Nordisk-rises-as-early-weightloss-pill-data-impresses-Street)

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire